Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction. Greene SJ, Fonarow GC. Eur Heart J 2023 Jul 5:ehad427. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Greene SJ, Fonarow GC. Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction. Eur Heart J 2023 Jul 5:ehad427. doi: 10.1093.
PMID: 37403607